Results 101 to 110 of about 5,147 (131)

Scleredema adultorum of Buschke over the abdomen during pregnancy: an uncommon presentation. [PDF]

open access: yesJ Turk Ger Gynecol Assoc
Sumanth TS   +3 more
europepmc   +1 more source

Nephrogenic Systemic Fibrosis: An Overview

Journal of the American College of Radiology, 2008
In 1997, a new fibrosing skin disorder became apparent among patients with renal disease. Nephrogenic systemic fibrosis, as this disorder has come to be known, has recently been tied to the administration of contrast agents containing gadolinium. This overview examines the discovery and elucidation of the major research accomplishments to date.
Shawn E Cowper
exaly   +3 more sources

Update on Nephrogenic Systemic Fibrosis

Magnetic Resonance Imaging Clinics of North America, 2008
Gadolinium-based contrast agents were for many years considered safe, but this is no longer the case. The least stable agents may trigger the development of nephrogenic systemic fibrosis (NSF), a generalized fibrotic disorder, in renal failure patients.
Henrik S Thomsen, Peter Marckmann
exaly   +4 more sources

Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)–subclinical nephrogenic systemic fibrosis?

Journal of the American Academy of Dermatology, 2010
Nephrogenic systemic fibrosis is a condition with significant and often debilitating cutaneous manifestations. Recent research on this disease has delineated an association between nephrogenic systemic fibrosis and exposure to magnetic resonance imaging studies using gadolinium-based contrast agents in patients with ongoing renal failure.
Alan Boyd   +2 more
exaly   +3 more sources

Nephrogenic systemic fibrosis

Orvosi Hetilap, 2007
A nefrogén szisztémás fibrosis, melyet korábban nefrogén fibrotizáló dermopathiaként említett az irodalom, egy ritka kórkép, mely vesebetegeknél jelentkezik. A kialakulását elsősorban gadolínium alapú MRI-kontrasztanyag alkalmazását követően észlelték beszűkült vesefunkciójú, többnyire dializált betegeken.
István, Pintér   +3 more
openaire   +4 more sources

Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy)

Current Opinion in Rheumatology, 2006
Nephrogenic systemic fibrosis, also known as nephrogenic fibrosing dermopathy, was first documented in 1997 as a scleroderma-like fibrosing entity of the skin in association with renal insufficiency. Rheumatologists, along with other specialists, may be the first to encounter these patients; and both a familiarity with the disorder and vigilance for ...
Anjela, Galan   +2 more
openaire   +2 more sources

Nephrogenic systemic fibrosis: An update

Current Rheumatology Reports, 2006
Nephrogenic systemic fibrosis (NSF), previously known as nephrogenic fibrosing dermopathy, is an emerging systemic fibrosing disorder that develops in the setting of renal insufficiency. Since its recognition in 1997, several case reports of NSF have been published in the rheumatology literature, reflecting the increasing incidence and recognition of ...
Shawn E, Cowper, Philip J, Boyer
openaire   +2 more sources

Rehabilitation in Nephrogenic Systemic Fibrosis

PM&R, 2009
A 58-year-old man was referred for outpatient evaluation as the result of functional loss resulting from NSF. The patient had a complicated medical history that included diabetes mellitus, coronary artery disease, hypothyroidism, atrial fibrillation, and renal failure for which he underwent kidney transplant.
Larissa, Ramaizel, James A, Sliwa
openaire   +2 more sources

Home - About - Disclaimer - Privacy